Chapter 2100 Flashcards
2103
Patent Examination Process
2104
Requirements of 35 U.S.C. 101
2014.01
Barred by Atomic Energy Act
2105
Patent Eligible Subject Matter — Living Subject Matter
2106
Patent Subject Matter Eligibility
2106.03
Eligibility Step 1: The Four Categories of Statutory Subject Matter
2106.04
Eligibility Step 2A: Whether a Claim is Directed to a Judicial Exception
2106.04(a)
Abstract Ideas
2106.04(a)(1)
Examples of Claims That Do Not Recite Abstract Ideas
2106.04(a)(2)
Abstract Idea Groupings
2106.04(a)(3)
Tentative Abstract Ideas
2106.04(b)
Laws of Nature, Natural Phenomena & Products of Nature
2106.04(c)
The Markedly Different Characteristics Analysis
2106.04(d)
Integration of a Judicial Exception Into A Practical Application
2106.04(d)(1)
Evaluating Improvements in the Functioning of a Computer, or an Improvement to Any Other Technology or Technical Field in Step 2A Prong Two
2106.04(d)(2)
Particular Treatment and Prophylaxis in Step 2A Prong Two
2106.05
Eligibility Step 2B: Whether a Claim Amounts to Significantly More
2106.05(a)
Eligibility Step 2B: Whether a Claim Amounts to Significantly More
2106.05(b)
Particular Machine
2106.05(c)
Particular Transformation
2106.05(d)
Well-Understood, Routine, Conventional Activity
2106.05(e)
Other Meaningful Limitations
2106.05(f)
Mere Instructions To Apply An Exception
2106.05(g)
Insignificant Extra-Solution Activity
2106.05(h)
Field of Use and Technological Environment
2106.06
Streamlined Analysis
2106.06(a)
Eligibility is Self Evident
2106.06(b)
Clear Improvement to a Technology or to Computer Functionality
2106.07
Formulating and Supporting Rejections For Lack Of Subject Matter Eligibility
2106.07(a)
Formulating a Rejection For Lack of Subject Matter Eligibility
2106.07(a)(1)
Form Paragraphs for use in Lack of Subject Matter Eligibility Rejections
2106.07(b)
Evaluating Applicant’s Response
2106.07(c)
Clarifying the Record
2107
Guidelines for Examination of Applications for Compliance with the Utility Requirement
2107.01
General Principles Governing Utility Rejections
2107.02
Procedural Considerations Related to Rejections for Lack of Utility
2107.03
Special Considerations for Asserted Therapeutic or Pharmacological Utilities
2109
Inventorship
2111
Claim Interpretation; Broadest Reasonable Interpretation
2111.01
Plain Meaning
2111.02
Effect of Preamble
2111.03
Transitional Phrases
2111.04
Adapted to,” “Adapted for,” “Wherein,” “Whereby,” and Contingent Clauses
2111.05
Functional and Nonfunctional Descriptive Material
2112
Requirements of Rejection Based on Inherency; Burden of Proof
2112.01
Composition, Product, and Apparatus Claims
2112.02
Process Claims
2113
Product-by-Process Claims
2114
Apparatus and Article Claims — Functional Language
2115
Material or Article Worked Upon by Apparatus
2116
Novel, Nonobvious Starting Material or End Product
2116.01
Novel, Nonobvious Starting Material or End Product
2117
Markush Claims
2120
Rejection on Prior Art
2120.01
Rejections Under 35 U.S.C. 102(a)(1) and (a)(2) and Pre-AIA 35 U.S.C. 102(a), (b), or (e): Printed Publication or Patent
2120.02
Rejections Under 35 U.S.C. 102(a)(1) or Pre-AIA 35 U.S.C. 102(a) or (b): Knowledge by Others, or Public Use, or On Sale
2121
Prior Art; General Level of Operability Required to Make a Prima Facie Case
2121.01
Use of Prior Art in Rejections Where Operability is in Question
2121.02
Compounds and Compositions — What Constitutes Enabling Prior Art
2121.03
Plant Genetics — What Constitutes Enabling Prior Art
2121.04
Apparatus and Articles — What Constitutes Enabling Prior Art
2122
Discussion of Utility in the Prior Art
2123
Rejection Over Prior Art’s Broad Disclosure Instead of Preferred Embodiments
2124
Exception to the Rule That the Reference Must be Prior Art
2124.01
Tax Strategies Deemed Within the Prior Art
2125
Drawings as Prior Art
2126
Availability of a Document as a “Patent” for Purposes of Rejection Under 35 U.S.C. 102(a) or Pre-AIA 35 U.S.C. 102(a), (b), and (d)
2126.01
Date of Availability of a Patent as a Reference
2126.02
Scope of Reference’s Disclosure Which Can Be Used to Reject Claims When the Reference Is a “Patent” but Not a “Publication”
2127
Domestic and Foreign Patent Applications as Prior Art
2128
“Printed Publications” as Prior Art
2128.01
Level of Public Accessibility Required
2128.02
Date Publication Is Available as a Reference
2129
Admissions as Prior Art
2131
Anticipation — Application of 35 U.S.C. 102
2131.01
Multiple Reference 35 U.S.C. 102 Rejections
2131.02
Genus-Species Situations
2131.03
Anticipation of Ranges
2131.04
Secondary Considerations
2131.05
Nonanalogous or Disparaging Prior Art
2132
Pre-AIA 35 U.S.C. 102(a)
2132.01
Overcoming a Pre-AIA 35 U.S.C. 102(a) Rejection based on a Printed Publication or Patent
2133
Pre-AIA 35 U.S.C. 102(b)
2133.01
Rejections of Continuation-In-Part (CIP) Applications
2133.02
Rejections Based on Publications and Patents
2133.02(a)
Overcoming a Pre-AIA 35 U.S.C. 102(b) Rejection Based on a Printed Publication or Patent
2133.03
Rejections Based on “Public Use” or “On Sale”
2133.03(a)
“Public Use”
2133.03(b)
“On Sale”
2133.03(c)
The “Invention”
2133.03(d)
“In This Country”
2133.03(e)
Permitted Activity; Experimental Use
2133.03(e)(1)
Commercial Exploitation
2133.03(e)(2)
Intent
2133.03(e)(3)
“Completeness” of the Invention
2133.03(e)(4)
Factors Indicative of an Experimental Purpose
2133.03(e)(5)
Experimentation and Degree of Supervision and Control
2134
Pre-AIA 35 U.S.C. 102(c)
2135
Pre-AIA 35 U.S.C. 102(d)
2135.01
The Four Requirements of Pre-AIA 35 U.S.C. 102(d)
2136
Pre-AIA 35 U.S.C. 102(e)
2136.01
Status of Unpublished or Published as Redacted U.S. Application as a Reference Under Pre-AIA 35 U.S.C. 102(e)
2136.02
Content of the Prior Art Available Against the Claims
2136.03
Critical Reference Date
2136.04
Different Inventive Entity; Meaning of “By Another”
2136.05
Overcoming a Rejection Under Pre-AIA 35 U.S.C. 102(e)
2136.05(a)
Antedating a Pre-AIA 35 U.S.C. 102(e) Reference
2136.05(b)
Showing The Reference Is Describing An Inventor’s Or At Least One Joint Inventor’s Own Work
2137
Pre-AIA 35 U.S.C. 102(f)